Unique ID issued by UMIN | UMIN000015796 |
---|---|
Receipt number | R000018383 |
Scientific Title | Randomized Double-Blind Multicenter Placebo-Controlled Study of Tranilast in Patients with Dysmenorrhea |
Date of disclosure of the study information | 2014/12/01 |
Last modified on | 2017/01/06 11:19:35 |
Randomized Double-Blind Multicenter Placebo-Controlled Study of Tranilast in Patients with Dysmenorrhea
Randomized Double-Blind Multicenter Placebo-Controlled Study of Tranilast in Patients with Dysmenorrhea
Randomized Double-Blind Multicenter Placebo-Controlled Study of Tranilast in Patients with Dysmenorrhea
Randomized Double-Blind Multicenter Placebo-Controlled Study of Tranilast in Patients with Dysmenorrhea
Japan |
Dysmenorrhea
Obstetrics and Gynecology |
Others
NO
To examine the effectiveness against dysmenorrhea of tranilast in placebo-controlled
Safety,Efficacy
Confirmatory
Explanatory
Not applicable
VAS of dysmenorrhea
Dysmenorrhea score
Lower abdominal pain during menstruation, low back pain, headache, degree of nausea
Other than during menstruation pelvic pain VAS
Serum CA125 concentration
TTF (Time to Treatment Failure)
(such as incidence of adverse events)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Medicine |
Tranilast administration of between 6 months
placebo administration of between 6 months
20 | years-old | <= |
45 | years-old | > |
Female
(1) age is less than 45 years of age or 20 years of age at the time of obtaining informed consent, menstrual cycle is 25-38 days patients
(2) patients with dysmenorrhea VAS is greater than or equal to 30mm
(3) patients symptoms of dysmenorrhea has been controlled by only the use of N-saids, which has been determined to be controlled by only N-Saids throughout the study period
(4) patients who do not wish to become pregnant during the study period
(5) for participation in the study, patients consent document person was obtained
(1) age is less than 45 years of age or 20 years of age at the time of obtaining informed consent, menstrual cycle is 25-38 days patients
(2) patients with dysmenorrhea VAS is greater than or equal to 30mm
(3) patients symptoms of dysmenorrhea has been controlled by only the use of N-saids, which has been determined to be controlled by only N-Saids throughout the study period
(4) patients who do not wish to become pregnant during the study period
(5) for participation in the study, patients consent document person was obtained
60
1st name | |
Middle name | |
Last name | Hidetaka Katabuchi |
Kumamoto University Hospital
Department of Obstetrics and Gynecology
1-1-1, Honjo, Chuo-ku, Kumamoto
096-373-5269
buchi@kumamoto-u.ac.jp
1st name | |
Middle name | |
Last name | Ritsuo Honda |
Kumamoto University Hospital
Department of Obstetrics and Gynecology
1-1-1, Honjo, Chuo-ku, Kumamoto
096-373-5269
ritz@kumamoto-u.ac.jp
Endometriosis / Tranilast Study Group
ASKA Pharmaceutical Co., Ltd.
Profit organization
NO
2014 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
2014 | Year | 10 | Month | 10 | Day |
2014 | Year | 12 | Month | 01 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2014 | Year | 11 | Month | 30 | Day |
2017 | Year | 01 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018383
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |